Drugs / TVC-PR1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00513578 | Jan 2007 → Jan 2009 | myelodysplastic syndrome | The Vaccine Company | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TVC-PR1 | “proteinase PR1 leukemia peptide vaccine (TVC-PR1)” NCT00513578 ↗ |
| Modality | Vaccine | “PR1 leukemia peptide vaccine” NCT00513578 ↗ |
| Route | Subcutaneous | “4 subcutaneous injections of PR1 leukemia peptide vaccine formulated in incomplete Freund's adjuvant (IFA)” NCT00513578 ↗ |